• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sodium-glucose cotransporter 2 inhibitors for chronic heart failure: The ultimate solution?

作者信息

Strachinaru Mihai, Roussoulières Ana, Manintveld Olivier C

机构信息

Department of Cardiology, Pulmonary Vascular Diseases and Heart failure Clinic, Brussels University Hospital-Erasme Hospital, Brussels, Belgium.

Department of Cardiology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.

出版信息

Eur J Heart Fail. 2023 Aug;25(8):1361-1363. doi: 10.1002/ejhf.2942. Epub 2023 Jun 27.

DOI:10.1002/ejhf.2942
PMID:37349853
Abstract
摘要

相似文献

1
Sodium-glucose cotransporter 2 inhibitors for chronic heart failure: The ultimate solution?
Eur J Heart Fail. 2023 Aug;25(8):1361-1363. doi: 10.1002/ejhf.2942. Epub 2023 Jun 27.
2
Sodium-glucose cotransporter 2 inhibitors in hospitalized heart failure patients: No time like now.
Eur J Heart Fail. 2023 Oct;25(10):1806-1807. doi: 10.1002/ejhf.3022. Epub 2023 Sep 10.
3
Recommendation for Appropriate Use of Sodium Glucose Cotransporter 2 Inhibitors in Treatment of Heart Failure.钠-葡萄糖协同转运蛋白2抑制剂在心力衰竭治疗中合理应用的推荐意见。
Circ J. 2023 Oct 25;87(11):1707-1709. doi: 10.1253/circj.CJ-23-0605. Epub 2023 Sep 22.
4
Letter regarding the article 'Little at a time: trying to understand the battery of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure'.
Eur J Heart Fail. 2023 Apr;25(4):598. doi: 10.1002/ejhf.2782. Epub 2023 Feb 6.
5
Sodium-glucose cotransporter 2 inhibitors reduce cardiovascular events in acute heart failure. A real-world analysis.
Eur J Intern Med. 2022 Oct;104:128-130. doi: 10.1016/j.ejim.2022.06.008. Epub 2022 Jun 27.
6
Effect of canagliflozin on N-terminal pro-brain natriuretic peptide in patients with type 2 diabetes and chronic heart failure according to baseline use of glucose-lowering agents.根据基线时降糖药物的使用情况，评估卡格列净对 2 型糖尿病合并慢性心力衰竭患者 N 末端脑利钠肽前体的影响。
Cardiovasc Diabetol. 2021 Sep 3;20(1):175. doi: 10.1186/s12933-021-01369-5.
7
Mortality Outcomes With Different Sodium-glucose Cotransporter-2 Inhibitors: Are They Dissimilar?
Endocr Pract. 2022 Oct;28(10):1107-1108. doi: 10.1016/j.eprac.2022.07.001. Epub 2022 Jul 9.
8
Use of Sodium-Glucose Cotransporter-2 Inhibitors in Clinical Practice for Heart Failure Prevention and Treatment: Beyond Type 2 Diabetes. A Narrative Review.钠-葡萄糖共转运蛋白 2 抑制剂在心力衰竭预防和治疗中的临床应用：超越 2 型糖尿病。一篇叙述性综述。
Adv Ther. 2022 Feb;39(2):845-861. doi: 10.1007/s12325-021-01989-z. Epub 2021 Dec 9.
9
Effect of canagliflozin on white blood cell counts in patients with type 2 diabetes and heart failure: A subanalysis of the randomized CANDLE trial.卡格列净对 2 型糖尿病合并心力衰竭患者白细胞计数的影响：随机 CANDLE 试验的亚组分析。
J Diabetes Investig. 2022 Dec;13(12):1990-1999. doi: 10.1111/jdi.13899. Epub 2022 Sep 16.
10
Letter by Koh Regarding Article, "Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)".科关于文章《钠-葡萄糖协同转运蛋白2抑制剂起始治疗患者与其他降糖药物相比心力衰竭和死亡风险更低：CVD-REAL研究（钠-葡萄糖协同转运蛋白2抑制剂新使用者心血管结局的比较有效性）》的信
Circulation. 2018 Feb 27;137(9):984-985. doi: 10.1161/CIRCULATIONAHA.117.030650.